Evogene Reports Fourth Quarter and Full Year 2024 Financial Results
Provided By PR Newswire
Last update: Mar 6, 2025
Conference call and webcast: today, March 6, 2025, 9:00 am ET
Financial Highlights:
REHOVOT, Israel, March 6, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based products, today announced its financial results for the fourth quarter and full year period ended December 31, 2024.
Read more at prnewswire.comNASDAQ:EVGN (11/19/2025, 2:52:48 PM)
1.16
-0.01 (-0.85%)
Find more stocks in the Stock Screener
